EFAVIRENZ Pages on BioPortfolio:

BioPortfolio - Efavirenz
Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets, 22nd December, 2009 ...
http://www.bioportfolio.com/indepth/Efavirenz.html...

BioPortfolio Biotechnology BioNews : live article
Results were comparable for patients taking the efavirenz combination, ... Baseline HIV RNA for patients in the efavirenz arm of the study was 67554 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - CYP2B6 publications
The 516G > T allele is associated with a defective metabolism of efavirenz (EFV) , which therefore may predispose to drug toxicity. ...
http://www.bioportfolio.com/gene/1555-CYP2B6/publications.ht...

BioPortfolio Biotechnology BioNews : live article
Truvada and Sustiva are also available in the United States as the fixed-dose product Atripla(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio News: Decision Resources - In 2018, Coformulation of ...
4 Jan 2010 ... coformulation of rilpivirine and Truvada with a more favorable side-effect profile than that of Atripla's efavirenz component, ...
http://www.bioportfolio.com/news/In-2018,-Coformulation-of-R...

Biotechnology News ATAZANAVIR_SULFATE Search
Enhanced Reyataz & Efavirenz Co-Pay Benefit Program announcement from Bristol- Myers-Squibb We are enhancing the Bristol-Myers Squibb Co-pay Benefit Program
...
http://www.bioportfolio.co.uk/ATAZANAVIR_SULFATE-news.htm...

BioPortfolio News: Mylan Inc. - Mylan Receives Tentative FDA ...
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (nNRTI) that has been found to be effective in many combination regimens for the treatment of ...
http://www.bioportfolio.com/news/Mylan-Receives-Tentative-FD...

BioPortfolio.com - BioWeb HIV AIDS zdv. toxoplasm. toxoplasma. smx ...
Drugs For HIV Infection Type Drug Side Effects Non-nucleoside reverse transcriptase inhibitors - Delavirdine Rash, headaches - Efavirenz Dizziness,
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Customised Email lists for specifically targeting professionals ...
lopinavir/ritonavir, with or without efavirenz. xxx@agr.gc.ca. Volatile Compounds of Dry Beans (Phaseolus vulgaris L.). xxx@korea.ac.kr ...
http://www.bioportfolio.com/pdf/gcmstox.pdf...

BioPortfolio Biotechnology BioNews : live article
This growth was driven primarily by Gilead's HIV product franchise, including the strong uptake of Atripla(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Results from other life science and pharmaceutical sites:

Efavirenz - Wikipedia, the free encyclopedia
Efavirenz (brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active
antiretroviral ...
http://en.wikipedia.org/wiki/Efavirenz...

AIDSinfo - HIV/AIDS Drug Information - Efavirenz
Efavirenz, also known as EFV or Sustiva, is a type of medicine called a non- nucleoside reverse transcriptase inhibitor (NNRTI). ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int_i...

Efavirenz: MedlinePlus Drug Information
Efavirenz is used with other medications to treat human immunodeficiency virus ( HIV) infection in patients with or without acquired immunodeficiency ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699004.htm...

AIDSinfo - HIV/AIDS Drug Information - Efavirenz / Emtricitabine ...
Efavirenz is a type of medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both emtricitabine and tenofovir DF are medicines called ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int_i...

Pharmacogenetics of plasma efavirenz exposure after treatment ...
BACKGROUND: Efavirenz has a long plasma half-life and a low genetic barrier to resistance. Simultaneously stopping treatment with all agents in ...
http://www.ncbi.nlm.nih.gov/pubmed/16392089...

Psychiatric Safety of Efavirenz.
Objective: Efavirenz (Sustiva) is known to cause psychiatric side effects. We sought to determine whether efavirenz can safely be used in patients with ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102240450.html...

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir ...
BACKGROUND: Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing
...
http://www.ncbi.nlm.nih.gov/pubmed/10601505...

Resistance to efavirenz (SUSTIVA) in vivo.
Efavirenz (SUSTIVA, DMP 266) is a potent inhibitor of the reverse transcriptase of HIV-1. In order to assess the potential for the development of resistance ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102236281.html...

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy ...
6 Aug 2008 ... CONTEXT: Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences ...
http://www.ncbi.nlm.nih.gov/pubmed/18677025...

Journal of Perinatology - Myelomeningocele in an Infant with ...
9 Jun 2005 ... We report a case of myelomeningocele in an infant whose mother was exposed to efavirenz during the first 16 weeks of pregnancy. ...
http://www.nature.com/jp/journal/v25/n8/full/7211343a.html...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.